Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RUCAPARIB CAMSYLATE Cause Prescribed underdose? 156 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 156 reports of Prescribed underdose have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 1.9% of all adverse event reports for RUCAPARIB CAMSYLATE.

156
Reports of Prescribed underdose with RUCAPARIB CAMSYLATE
1.9%
of all RUCAPARIB CAMSYLATE reports
5
Deaths
23
Hospitalizations

How Dangerous Is Prescribed underdose From RUCAPARIB CAMSYLATE?

Of the 156 reports, 5 (3.2%) resulted in death, 23 (14.7%) required hospitalization.

Is Prescribed underdose Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RUCAPARIB CAMSYLATE. However, 156 reports have been filed with the FAERS database.

What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?

Fatigue (2,494) Nausea (2,219) Malignant neoplasm progression (1,162) Decreased appetite (787) Constipation (763) Diarrhoea (759) Vomiting (759) Asthenia (660) Adverse event (571) Carbohydrate antigen 125 increased (562)

What Other Drugs Cause Prescribed underdose?

NATALIZUMAB (2,162) SACUBITRIL\VALSARTAN (1,864) APIXABAN (1,469) ABATACEPT (1,192) PIMAVANSERIN (1,165) FINGOLIMOD (1,114) RITUXIMAB (1,067) METHOTREXATE (1,066) ADALIMUMAB (1,010) TOCILIZUMAB (1,002)

Which RUCAPARIB CAMSYLATE Alternatives Have Lower Prescribed underdose Risk?

RUCAPARIB CAMSYLATE vs RUFINAMIDE RUCAPARIB CAMSYLATE vs RUPATADINE RUCAPARIB CAMSYLATE vs RUXOLITINIB RUCAPARIB CAMSYLATE vs SABRIL RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE

Related Pages

RUCAPARIB CAMSYLATE Full Profile All Prescribed underdose Reports All Drugs Causing Prescribed underdose RUCAPARIB CAMSYLATE Demographics